Business

Veklury antiviral coronavirus treatment vials recalled by Gilead Sciences

Orignally published on 2021-12-04 11:41:18 by www.washingtonpost.com

The California-based company did not immediately respond to a request for comment from The Washington Post late on Friday, but company spokesman Chris Ridley told Bloomberg the recall involved some 55,000 vials of the drug, enough to treat 11,000 hospitalized patients.

Orignally published on 2021-12-04 11:41:18 by www.washingtonpost.com

Back to top button